Matrix metalloproteinases (MMPs) in oral diseases

被引:439
作者
Sorsa, T
Tjäderhane, L
Salo, T
机构
[1] Univ Helsinki, Biomedicum, Inst Dent, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland
[3] Invalid Fdn, Orthopaed Hosp, ORTON Res Inst, Helsinki, Finland
[4] Univ Oulu, Inst Dent, Oulu, Finland
[5] Oulu Univ Hosp, Oulu, Finland
关键词
matrix metalloproteinases; oral; periodontitis; cancer; caries;
D O I
10.1111/j.1601-0825.2004.01038.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Matrix metalloproteinases (MMPs) are a group of enzymes that in concert are responsible for the degradation of most extracellular matrix proteins during organogenesis, growth and normal tissue turnover. The expression and activity of MMPs in adult tissues is normally quite low, but increases significantly in various pathological conditions that may lead into unwanted tissue destruction, such as inflammatory diseases, tumour growth and metastasis. MMPs have a marked role also in tissue destructive oral diseases. The role of collagenases, especially MMP-8, in periodontitis and peri-implantitis is the best-known example of the unwanted tissue destruction related to increased presence and activity of MMPs at the site of disease, but evidence has been brought forward to indicate that MMPs may be involved also in other oral diseases, such as dental caries and oral cancer. This brief review describes some of the history, the current status and the future aspects of the work mainly of our research groups looking at the presence and activity of various MMPs in different oral diseases, as well as some of the MMP-related aspects that may facilitate the development of new means of diagnosis and treatment of oral diseases.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 73 条
[1]   Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model [J].
Agarwal, D ;
Goodison, S ;
Nicholson, B ;
Tarin, D ;
Urquidi, V .
DIFFERENTIATION, 2003, 71 (02) :114-125
[2]   The in vivo levels of matrix metalloproteinase-1 and -8 in gingival crevicular fluid during initial orthodontic tooth movement [J].
Apajalahti, S ;
Sorsa, T ;
Railavo, S ;
Ingman, T .
JOURNAL OF DENTAL RESEARCH, 2003, 82 (12) :1018-1022
[3]   Loss of collagenase-2 confers increased skin tumor susceptibility to male mice [J].
Balbín, M ;
Fueyo, A ;
Tester, AM ;
Pendás, AM ;
Pitiot, AS ;
Astudillo, A ;
Overall, CM ;
Shapiro, SD ;
López-Otín, C .
NATURE GENETICS, 2003, 35 (03) :252-257
[4]   Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide [J].
Bannikov, GA ;
Karelina, TV ;
Collier, IE ;
Marmer, BL ;
Goldberg, GI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :16022-16027
[5]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[6]  
CARRILHO MRO, 2004, IN PRESS DENT MAT
[7]   Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: A phase I AIDS malignancy consortium study [J].
Cianfrocca, M ;
Cooley, TP ;
Lee, JY ;
Rudek, MA ;
Scadden, DT ;
Ratner, L ;
Pluda, JM ;
Figg, WD ;
Krown, SE ;
Dezube, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :153-159
[8]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392
[9]  
Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO
[10]  
2-C